May 19, 2020

NIH begins clinical trial of hydroxychloroquine, azithromycin for COVID-19 treatment

By: Judy Mathias

Editor's Note

The National Institutes of Health (NIH) on May 14 announced that it is enrolling adults with mild to moderate COVID-19 in a study of treatment with hydroxychloroquine and azithromycin.

The Phase 2b trial is enrolling around 2,000 adults across the US. Participants must have confirmed infection with SARS-CoV-2 and be experiencing fever, cough, and/or shortness of breath.

Sponsored Message

The participants will be randomly assigned to short-term treatment with either hydroxychloroquine and azithromycin or matching placebos.


Sign Up For OR a.m.
Sign up for the free OR a.m. eLetter to get news like this in your inbox every morning!

OR Manager Jobs
Live chat by BoldChat